Percent free prostate-specific antigen after radiotherapy for prostate cancer - 8 to 10 ng/mL total PSA

By Crook J.M.   Bunting P.S.  

Urology, Vol. 52, Iss. 1, 1998-07 ,pp. : 100-105

Elsevier

Access to resources Recommend Favorite

Comparison of two investigative assays for the complexed prostate-specific antigen in total prostate-specific antigen between 4.1 and 10.0 ng/mL

By Okegawa T.   Noda H.   Nutahara K.   Higashihara E.  

Urology, Vol. 55, Iss. 5, 2000-05 ,pp. : 700-704

Elsevier

Access to resources Recommend Favorite

Use of percentage of free prostate-specific antigen to identify men at high risk of prostate cancer when psa levels are 2.51 to 4 ng/mL and digital rectal examination is not suspicious for prostate cancer: an alternative model

By Catalona W.J.   Partin A.W.   Finlay J.A.   Chan D.W.   Rittenhouse H.G.   Wolfert R.L.   Woodrum D.L.  

Urology, Vol. 54, Iss. 2, 1999-08 ,pp. : 220-224

Elsevier

Access to resources Recommend Favorite

The Prostate Health Index in predicting initial prostate biopsy outcomes in Asian men with prostate-specific antigen levels of 4–10 ng/mL

By Ng C.   Chiu Peter   Lam N.   Lam H.   Lee Kim   Hou Simon  

International Urology and Nephrology, Vol. 46, Iss. 4, 2014-04 ,pp. : 711-717

Springer Publishing Company

Access to resources Recommend Favorite

Clinical value of human glandular kallikrein 2 and free and total prostate-specific antigen in serum from a population of men with prostate-specific antigen levels 3.0 ng/mL or greater

By Becker C.   Piironen T.   Pettersson K.   Hugosson J.   Lilja H.  

Urology, Vol. 55, Iss. 5, 2000-05 ,pp. : 694-699

Elsevier

Access to resources Recommend Favorite